<DOC>
	<DOCNO>NCT01756521</DOCNO>
	<brief_summary>The purpose study evaluate effect moxifloxacin QT/QTc interval healthy male subject . Moxifloxacin positive control drug use QT study . In study , moxifloxacin 400mg 800mg use , get information effect moxifloxacin QT/QTc interval .</brief_summary>
	<brief_title>A Study Study Investigate Effect QT/QTc Interval Moxifloxacin After Single Dose Healthy Male Subjects</brief_title>
	<detailed_description>The purpose study evaluate effect moxifloxacin QT/QTc interval healthy male subject . Moxifloxacin positive control drug use QT study . In study , moxifloxacin 400mg 800mg use , ( therapeutic supratherapeutic dos ) get information effect moxifloxacin QT/QTc interval healthy Korean male subject .</detailed_description>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>healthy male subject age 20 40 screening subject weight 50 kg ideal body weight range + 20 % subject decide participate voluntarily write informed consent form subject acute illness within 28 day investigational drug administration subject clinically significant disease cardiovascular , respiratory , renal , endocrinological , hematological , gastrointestinal , neurological ( central nervous system ) , psychiatric disorder malignant tumor subject determine eligible screen test ( medical history , physical examination , 12lead ECG , laboratory test , etc ) within 28 day study start clinically significant allergic disease ( except mild allergic rhinitis ) systolic blood pressure &gt; = 140 mmHg , diastolic blood pressure &gt; = 90 mmHg , heart rate &gt; 100 bpm &lt; 50 bpm result 12lead electrocardiogram include : QTcF &gt; 450 msec PR interval &gt; 200 msec &lt; 110msec Evidence second thirddegree atrioventricular ( AV ) block Pathologic Q wave ( define Qwave &gt; 40 msec depth &gt; 0.5 millivolt Evidence ventricular preexcitation , leave bundle branch block ( LBBB ) , right bundle branch block ( RBBB ) Intraventricular conduction delay QRS &gt; 120 msec risk Torsade de pointes long QT syndrome , family history sudden death , heart failure , hypokalemia Subjects consider unsuitable inclusion investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>QT ,</keyword>
	<keyword>QTc ,</keyword>
	<keyword>electrocardiogram ,</keyword>
	<keyword>moxifloxacin</keyword>
</DOC>